세계의 광견병 항혈청 시장 : 유형별, 용도별, 유통 채널별, 지역별

The global rabies antiserum market size was valued at USD 1.24 billion in 2023. The market is projected to grow at a CAGR of 3.3% from 2023 to 2030, resulting in an estimated market size of USD 1.56 billion by the end of 2030.

Fig 1. Global Rabies Antiserum Market Share (%) By Region, 2023

Rabies antiserum is used to protect people who have been exposed to a potentially rabid animal. Rabies is a serious, almost always fatal disease that spreads from the saliva (spit) of an infected animal through a bite or scratch to humans and other animals. It can be prevented by getting immediate medical care and immunizations after the exposure. It is recommended that travelers to high-risk areas have a pre-exposure rabies vaccine series and be prepared with post-exposure prophylaxis (PEP) in case they are bitten or scratched by an infected animal. There are two types of rabies immunoglobulin available: human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). HRIG is preferable when it is available, but if it is not, ERIG will be effective in neutralizing the rabies virus.

Market Dynamics:

The need to prevent rabies and the rising incidence of dog bites are expected to support growth of the rabies antiserum market. Additionally, the growing awareness regarding rabies vaccinations is also expected to propel growth of the market. Moreover, technological advancements and changing consumer behavior are other major factors expected to drive growth of the market over the forecast period.

On the other hand, a lack of awareness regarding advanced technology is expected to restrict market growth. Limited efforts by government public health agencies and international organizations towards awareness-generation activities have also restricted market growth. According to the WHO, in 2021, over 109 countries reported rabies cases in both humans and animals. But national surveillance systems were weak to reliably record the true incidence in many poorer nations. Without accurate epidemiological data available in the public domain, the real threat posed by rabies tends to get underestimated. This acts as a major roadblock in mobilizing necessary policy attention and resources for expanding rabies prevention programs, including the supply of biologics like antiserum.

Key features of the study:

• This report provides in-depth analysis of the global rabies antiserum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global rabies antiserum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine, Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., and Beijing Tiantan Biological Products Co. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global rabies antiserum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rabies antiserum market

Detailed Segmentation:

• Rabies Antiserum Market, By Type
  • Monoclonal Antibodies (mAbs)
  • Polyclonal Antibodies
• Rabies Antiserum Market, By Application
  • Pre-Exposure Prophylaxis (PrEP)
  • Post-Exposure Prophylaxis (PEP)
• Rabies Antiserum Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Rabies Antiserum Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Key Players
  • CSL Behring
  • Sanofi Pasteur
  • Grifols S.A.
  • Bharat Serum and Vaccines Ltd.
  • Novartis AG
  • Kedrion Biopharma Inc.
  • Biogenesis Bago SA
  • Serum Institute of India Ltd.
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Shanghai Institute of Biological Products Co. Ltd.
  • CNBG (China National Biotec Group) Co. Ltd.
  • Harbin Pharmaceutical Group Co. Ltd.
  • Beijing Tiantan Biological Products Co. Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Rabies Antiserum, By Type
  • Market Rabies Antiserum, By Application
  • Market Rabies Antiserum, By Distribution Channel
  • Market Rabies Antiserum, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising incidence of dog bites
• Growing awareness regarding rabies vaccinations
  • Restraints
• Lack of awareness regarding advanced technologies
  • Opportunities
• Supportive government initiatives
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Rabies Antiserum Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Rabies Antiserum Market , By Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Monoclonal Antibodies (mAbs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
• Polyclonal Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)

6. Rabies Antiserum Market , By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Pre-Exposure Prophylaxis (PrEP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
• Post-Exposure Prophylaxis (PEP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Rabies Antiserum Market , By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Rabies Antiserum Market , By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2023 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi Pasteur
• Grifols S.A
• Bharat Serum and Vaccines Ltd.
• Novartis AG
• Kedrion Biopharma Inc.
• Biogenesis Bago SA
• Serum Institute of India Ltd.
• Haffkine Bio-Pharmaceutical Corporation Ltd.
• Shanghai Institute of Biological Products Co. Ltd.
• CNBG (China National Biotec Group) Co. Ltd.
• Harbin Pharmaceutical Group Co. Ltd.
• Beijing Tiantan Biological Products Co. Ltd.
• Analyst Views

10. Section

• Research Methodology
• About us